Trends and emerging technologies in extracorporeal life support: Results of the 2006 ECLS survey

Journal of Extra-Corporeal Technology

Volumn 41, Issue 2, 2009, Pages 73-78

  Sievert, Alicia N ^a   Shackelford, Anthony G ^a   McCall, Mary M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anticoagulation; Coated tubing; Extracorporeal life support; Extracorporeal membrane oxygenation; Oxygenators; Survey

Indexed keywords

ANTIBIOTIC AGENT; ARGATROBAN; HEPARIN; HIRULOG; SILICONE;

BLOOD CLOTTING; BLOOD CLOTTING TIME; CLINICAL PRACTICE; CONFERENCE PAPER; EXTRACORPOREAL CIRCULATION; HEART LUNG MACHINE; HEPARIN INDUCED THROMBOCYTOPENIA; HOLLOW FIBER MEMBRANE; HUMAN; MEDICAL SPECIALIST; OXYGENATOR; PARTIAL THROMBOPLASTIN TIME; THROMBOCYTE COUNT; UNITED STATES; ARTICLE; EPIDEMIOLOGY; HEART ASSIST DEVICE; INSTRUMENTATION;

EXTRACORPOREAL CIRCULATION; HEALTH CARE SURVEYS; HEART-ASSIST DEVICES; HUMANS; OXYGENATORS; UNITED STATES;

EID: 70349577615     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Hill JG, O'Brien TG, Murray JJ, et al. Extracorporeal oxygen for acute post-traumatic respiratory failure (shock lung syndrome): Use of the Bramson membrane lung. N Engl J Med. 1972;286:629.
2. Bartlett RH, Gazzaniga AB, Jefferies MR, et al. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs. 1976;22:80-93.
3. Bartlett RH. Extracorporeal oxygenation in infants. Hosp Pract. 1984;19:139-51.
4. Bartlett RH, Gazzaniga AB, Toomasian J, et al. Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure: 100 cases. Ann Surg. 1986;40:519-27.
5. Wolfson PJ. The development and use of extracorporeal membrane oxygenation in neonates. Ann Thorac Surg. 2003;76:S2224-9.
6. Duncan BW, Hraska V, Jonas RA, et al. Mechanical circulatory support for pediatric cardiac patients, Circulation. 1996;94(Suppl): I173.
7. Duncan BW, Ibrahim AE, Hraska V, et al. Use of rapid-deployment extracorporeal membrane oxygenation for the resuscitation of pediatric patients with heart disease after cardiac arrest. J Thorac Cardiovasc Surg. 1998;116:305-11.
8. Abderson HL, Delius RE, Sinard JM, et al. Early experience with adult extracorporeal membrane oxygenation in the modern era. Ann Thorac Surg. 1992;53:553-63.
9. Anderson HL, Steimle C, Sharpiro MB, et al. Extracorporeal life support for adult cardiorespiratory failure. Surgery. 1993;114: 161-73.
10. Allison P, Kurusz M, Graves D, et al. Devices and monitoring during neonatal ECMO: Survey results. Perfusion. 1990;5:193-201.
11. Lawson DS, Walczak R, Lawson AF, et al. North American neonatal extracorporeal membrane oxygenation (ECMO) devices: 2002 survey results. J Extra Corpor Technol. 2004;36:16-21.
12. Agati A, Mignosa C, Ciccarello G, Dario A, Undar A. Pulsatile ECMO in neonates and infants: First European clinical experience with a new device. ASAIO J. 2005;51:508-12.
13. Searles B, Gunst G, Terry B, et al. 2004 survey of ECMO in the neonate after open heart surgery: Circuitry and team roles. J Extra Corpor Technol. 2005;37:351-4.
14. Horton S, Thuys C, Bennett M, Augustin S, Rosenberg M, Brizard C. Experience with the Jostra Rotaflow and Quadrox D oxygenator for ECLS. Perfusion. 2004;19:17-23.
15. Khoshbin E, Westrope C, Pooboni S, et al. Performance of poly methyl pentene oxygenators for neonatal extracorporeal membrane oxygenation: a comparison with silicone membrane oxygenators. Perfusion. 2005;20:129-34.
16. Lappegard KT, Fung M, Bergseth G, et al. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation. Ann Thorac Surg. 2004;77:932-41.
17. Moen O, Hogasen K, Fosse E, et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 1997;63:105-11.
18. Izuha H, Hattori M, Igari T, Wakamatsu D, Watanabe M, Yokoyama H. Changes in platelet aggregation during cardiopulmonary bypass: Comparison of poly-2-methoxyethylacrylate and heparin as a circuit coating material. J Artif Organs. 2005;8:41-6.
19. Meinhardt JP, Annich GM, Miskulin J, et al. Thrombogenicity is not reduced when heparin and phsopholipid bonded circuits are used in a rabbit model of extracorporeal circulation. ASAIO J. 2003;49:395-400.
20. Tayama E, Hayashida N, Akasu K. Biocompatibility of heparin-coated extracorporeal bypass circuits: New heparin bonded bioline system. J Artif Organs. 2000;24:618-23.
21. Ikuta T, Fujii H, Shibata T, et al. A new poly-2-methoxyethylacrylate- coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy. Ann Thorac Surg. 2004;77:1678-83.
22. Ota K, Tatsumi E, Taenaka Y, et al. Prolonged heparinless animal testing of a newly developed antithrombogenic heparin-coated pediatric ECMO system. Pulmonary abstracts. ASAIO J. 2005; 51:48a.
23. Koster A, Sanger S, Hansen R, et al. Prevalence and persistence of heparin/platelet factor IV antibodies in patients with heparin coating and non-coated ventricular assist devices. ASAIO J. 2000;46: 319-22.
24. Yamakasi Y, Hayashi T, Yotsuida H, et al. Early experience with lowprime (99ml) extra corporeal membrane oxygenation support in children. ASAIO J. 2006;52:110-4.
25. Ambrose TM, Parvin CA, Mendeloff E, Luchtman-Jones L. Evaluation of the TAS analyzer and the low-range heparin management test in patients undergoing extracorporeal membrane oxygenation. Clin Chem. 2001;47:858-66.
26. Owings JT, Pollock ME, Gosselin RC, et al. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques. Arch Surg. 2000;135:1042-7.
27. Codispoti M, Ludlam CA, Simpson D, Mankad PS. Individualized heparin and protamine administration in infants and children undergoing cardiac operations. Ann Thorac Surg. 2001;71:922-8.
28. Baird C, Gabdhi D, Zurakowski D, et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: Impact of activated clotting time and heparin dose. Presented at the 42nd Annual Meeting of the Society of Thoracic Surgeons, Chicago, IL, January 30 to February 1, 2006.
29. Bull BS, Korpman RA, Huse WM, Briggs BD. Heparin therapy during extracorporeal circulation: II The use of a dose response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685-9.
30. Cheung AT, Levin SK, Weiss SJ, et al. Intracardiac thrombus: A risk of incomplete anticoagulation for cardiac operations. Ann Thorac Surg. 1994;58:541-2.
31. Despotis GJ, Joist JH, Hogue CW, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 1995;110: 46-54.
32. Jaggers JJ, Neal MC, Smith PK, Ungerleider RM, Lawson JH. Infant cardiopulmonary bypass: A procoagulant state. Ann Thorac Surg. 1999;68:513-20.